BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35150970)

  • 21. Nitro-Oleic Acid (NO
    Braumann S; Schumacher W; Im NG; Nettersheim FS; Mehrkens D; Bokredenghel S; Hof A; Nies RJ; Adler C; Winkels H; Knöll R; Freeman BA; Rudolph V; Klinke A; Adam M; Baldus S; Mollenhauer M; Geißen S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
    Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
    Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
    Inomata M; Kamio K; Azuma A; Matsuda K; Kokuho N; Miura Y; Hayashi H; Nei T; Fujita K; Saito Y; Gemma A
    Respir Res; 2014 Feb; 15(1):16. PubMed ID: 24507087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis.
    Liu T; Yu H; Ullenbruch M; Jin H; Ito T; Wu Z; Liu J; Phan SH
    PLoS One; 2014; 9(2):e88362. PubMed ID: 24516640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.
    Ritzenthaler JD; Zhang M; Torres-Gonzalez E; Roman J
    Lung; 2020 Dec; 198(6):947-955. PubMed ID: 33146772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
    Kimura T; Nojiri T; Hino J; Hosoda H; Miura K; Shintani Y; Inoue M; Zenitani M; Takabatake H; Miyazato M; Okumura M; Kangawa K
    Respir Res; 2016 Feb; 17():19. PubMed ID: 26895702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts.
    Takenouchi Y; Kitakaze K; Tsuboi K; Okamoto Y
    Exp Cell Res; 2020 Jun; 391(2):112010. PubMed ID: 32305327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis.
    Hu B; Wu Z; Bai D; Liu T; Ullenbruch MR; Phan SH
    Am J Pathol; 2015 Nov; 185(11):3066-75. PubMed ID: 26358219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro.
    Speca S; Dubuquoy C; Rousseaux C; Chavatte P; Desreumaux P; Spagnolo P
    PLoS One; 2021; 16(9):e0257281. PubMed ID: 34529707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
    Zhu T; Zhang W; Xiao M; Chen H; Jin H
    Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.